Human Latent TGF beta-1 Flow Cytomtery Assay |
|
HX87434 |
Antigenix America |
96 tests |
EUR 270 |
Human IgG antibody Laboratories manufactures the adding tgf beta to jurkat assay reagents distributed by Genprice. The Adding Tgf Beta To Jurkat Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact tgf assay. Other Adding products are available in stock. Specificity: Adding Category: Tgf Group: Beta To
Human TGF-beta-3 Antibody |
|
AssayPro |
150 ug |
EUR 215 |
Beta To information
Jurkat cell Lysate (untreated) |
|
2401-100 |
Biovision |
each |
EUR 222 |
Jurkat Cell Extract (Uninduced) |
|
1106-1000 |
Biovision |
each |
EUR 379.2 |
Jurkat Cell Extract (Uninduced) |
|
1106-400 |
Biovision |
each |
EUR 222 |
CRISPRa (SAM) Jurkat Cell Pool |
|
78080 |
BPS Bioscience |
2 million cells |
EUR 795 |
|
Description: This cell line has been engineered for use with the CRISPR Synergistic Activation Mediator (SAM) system to induce transcriptional activation and expression of any gene of interest. Cells stably express a mutated dCas9 (Streptococcus pyogenes CRISPR associated protein 9), lacking any endonuclease activity, fused to VP64, a transcriptional activator. Stable dCas9-VP64 expression is maintained with Blasticidin resistance. Cells also stably express P65 (Transcription Factor p65, or Nuclear Factor NF-κB p65) and HSF1 (Heat Shock Factor 1) fused with an MS2 tag, which is maintained with Hygromycin resistance. When these cells are transfected with an MS2-tagged sgRNA targeting the promoter region of the gene of interest, dCas9-VP64 and MS2-P65-HSF1 are recruited to the site in the genomic DNA and begin transcription, inducing expression of the desired gene. |
Jurkat-Lucia™ NFAT Cells |
|
jktl-nfat |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1289.4 |
B2M Knockout Jurkat Cell Line |
|
78342 |
BPS Bioscience |
2 vials |
EUR 6500 |
|
Description: B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from Jurkat cells. |
TCR Knockout Jurkat Cell Line |
|
78539 |
BPS Bioscience |
2 vials |
EUR 6500 |
|
Description: The TCR Knockout Jurkat cell line was generated by CRISPR/Cas9 genome editing to remove the TRAC (T-Cell Receptor Alpha Constant) and TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα and β chains. |
JURKAT FFPE Cell Pellet Block |
|
LeFFPE-CP007 |
Creative Bioarray |
1 Block |
Ask for price |
|
Description: Leukemia |
Human Jurkat Whole Cell Lysate |
|
LYSATE0027 |
BosterBio |
200ug |
EUR 180 |
|
Description: This cell lysate is prepared from human Jurkat using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
Human Jurkat Whole Cell Lysate |
|
IHUJURKATTLW500UG |
Innovative research |
each |
EUR 327 |
|
|
|
Description: Human Jurkat Whole Cell Lysate |
JURKAT FFPE Cell Pellet Slides |
|
LeFFPE-CP008 |
Creative Bioarray |
5 Slides |
Ask for price |
|
Description: Leukemia |
STAT3 Reporter Jurkat Cell Line |
|
78497 |
BPS Bioscience |
2 vials |
EUR 1900 |
|
Description: The STAT3 Reporter Jurkat cell line is designed for monitoring the STAT3 signal transduction pathway. It contains a firefly luciferase gene driven by STAT3 response elements located upstream of the minimal TATA promoter. After activation by cytokines or growth factors, endogenous STAT3 binds to the DNA response elements, inducing transcription of the luciferase reporter gene. |
JURKAT FFPE Cell Pellet Scrolls |
|
LeFFPE-CP009 |
Creative Bioarray |
5 Scrolls |
Ask for price |
|
Description: Leukemia |
Cas9 Expressing Jurkat Cell Line |
|
T3261 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 795 |
Jurkat, Clone E6-1 Cell Line |
|
CL-0129 |
Elabscience Biotech |
1×10⁶ cells/vial |
EUR 420 |
|
|
|
Description: Homo sapiens, Human |
Cas9-Expressing Jurkat cell pool |
|
78070 |
BPS Bioscience |
2 million cells |
EUR 795 |
|
Description: Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene. Cas9-expressing Jurkat cells can be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines. |
